1. Bastos-Rodrigues, L. et al. (2006) The genetic structure of human populations studied through short insertion-deletion polymorphisms. Annals of Human Genetics, 70, pp. 658–665.
2. Estrela, R. C. E. et al. (2008a) The distribution of ABCB1 polymorphisms among Brazilians: Impact of population admixture. Pharmacogenomics, 9, pp. 267–276.
3. Estrela, R. C. E. et al. (2008b) CYP3A5 genotype has no impact on plasma trough concentrations of lopinavir and ritonavir in HIV-infected subjects. Clinical Pharmacology&Therapeutics, 84, pp. 205–207.
4. Estrela, R. C. E. et al. (2009) ABCB1 polymorphisms have no impact on the concentrations of lopinavir and ritonavir in blood, semen and saliva of HIV- i nfected men under stable antiretroviral therapy. Pharmacogenomics, 10, pp. 311–318.
5. Gage, B. F. et al. (2008) Use of pharmacogenetic and clinical factors to predict the therapeutic dose of warfarin. Clinical Pharmacology&Therapeutics, 84, pp. 326–331.